Redmile Group, LLC Hookipa Pharma Inc. Transaction History

Redmile Group, LLC

$1.53 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.86 $934,374 - $1.91 Million	-2,224,700 Reduced 67.65%	1,063,769 $861,000
Q2 2023 Aug 14, 2023	BUY	$0.71 - $1.97 $522,219 - $1.45 Million	735,520 Added 28.81%	3,288,469 $2.89 Million
Q1 2023 May 15, 2023	SELL	$0.72 - $1.03 $404,509 - $578,673	-561,819 Reduced 18.04%	2,552,949 $1.89 Million
Q4 2022 Feb 14, 2023	SELL	$0.73 - $14.6 $1.06 Million - $21.1 Million	-1,447,480 Reduced 31.73%	3,114,768 $2.52 Million
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $98,952 - $171,864	-74,400 Reduced 1.6%	4,562,248 $7.44 Million
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $2.84 Million - $5.67 Million	2,251,512 Added 94.4%	4,636,648 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.94 $1.26 Million - $3.21 Million	540,831 Added 29.32%	2,385,136 $5.56 Million
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $70,091 - $111,265	-11,900 Reduced 0.64%	1,844,305 $10.9 Million
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $121,855 - $259,541	13,303 Added 0.72%	1,856,205 $17 Million
Q3 2020 Nov 16, 2020	SELL	$8.59 - $11.89 $152,111 - $210,548	-17,708 Reduced 0.95%	1,842,902 $17.5 Million
Q2 2020 Aug 14, 2020	SELL	$7.23 - $12.1 $13,737 - $22,990	-1,900 Reduced 0.1%	1,860,610 $21.6 Million
Q1 2020 May 15, 2020	SELL	$5.9 - $13.8 $177,064 - $414,151	-30,011 Reduced 1.59%	1,862,510 $15.4 Million
Q4 2019 Feb 14, 2020	SELL	$6.51 - $12.23 $33,852 - $63,596	-5,200 Reduced 0.27%	1,892,521 $23.1 Million
Q3 2019 Nov 14, 2019	BUY	$6.45 - $8.44 $37,680 - $49,306	5,842 Added 0.31%	1,897,721 $14.2 Million
Q2 2019 Aug 14, 2019	BUY	$6.16 - $14.15 $11.7 Million - $26.8 Million	1,891,879 New	1,891,879 $12.7 Million

Others Institutions Holding HOOK

# of Institutions

Shares Held

677K

Call Options Held

Put Options Held

View Full List

About HOOKIPA Pharma Inc.

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $155M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

More about HOOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account